iShares U.S. Healthcare ETF IYH
78.95 USD +0.33 (+0.42%)
Regular-session close
83.40 +4.45 +5.64%
After hours · Nov 13, 4:45 PM ET
78.26 Day range 79.11
59.98 52-week range 79.85
- YTD
- +21.27%
- 1 year
- +22.92%
News
defenseworld.net Commonwealth Equity Services LLC Buys New Holdings in iShares U.S. Healthcare ETF $IYH Commonwealth Equity Services LLC bought a new stake in iShares U.S. Healthcare ETF (NYSEARCA:IYH) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange…
seekingalpha.com Biotech Is Booming; Here Are 4 Names Outperforming Despite This Deep Correction I build my biotech investments using technical analysis, focusing on price action and volume, not traditional fundamentals. I target small-cap biotechs advancing past Phase 2, especially those…
benzinga.com Kalshi, Polymarket Put Democrats' Senate Odds At More Than 70%: 5 ETFs That Could Move If They're Wrong Kalshi and Polymarket give Democrats 73.5% Senate odds. Here are five ETFs that could react if the predictions miss.
benzinga.com Target, Truist Financial And More On CNBC’s ‘Final Trades’ CNBC’s final trades: Joshua Brown picks Target, Stephanie Link chooses Truist Financial, and Shannon Saccocia recommends iShares U.S. Healthcare ETF.
benzinga.com J.B. Hunt Transport, LPL Financial And More On CNBC’s ‘Final Trades’ Experts on CNBC's Halftime Report recommend Roundhill Memory ETF, iShares U.S. Healthcare ETF, and J.B. Hunt Transport.
benzinga.com Justin Wolfers Warns of a 'Pink Collar' Economy Amid July Jobs Report: 'If You Don't Wear Scrubs… You're Losing Jobs' Economist Justin Wolfers warns of a 'pink collar' economy as the U.S. sheds 23,000 jobs in July, with only the healthcare sector hiring.
benzinga.com Apple, Micron, Rocket Companies And More On CNBC’s ‘Final Trades’ Lebenthal picks Micron, Ethridge chooses Rocket Companies, Saccocia recommends iShares U.S. Healthcare ETF, and Brown selects Apple on CNBC's Halftime Report
benzinga.com UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
benzinga.com White House Reportedly Preparing To Oust FDA Commissioner Marty Makary Trump considers Kyle Diamantas for acting FDA chief as Marty Makary faces potential removal. Stay updated on the leadership transition.
benzinga.com Okta, Phillips 66 And More: CNBC's 'Final Trades' Okta shares rose 3% to close at $80.76 on Thursday while Phillips 66 shares gained 3.2% to settle at $178.34.
benzinga.com AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss AbbVie shares fall after early trial data for its obesity drug show up to 9.79% weight loss with generally mild side effects.
benzinga.com FDA Approval For AbbVie/AstraZeneca's Combination Treatment Could Set New Standard For Slow Growing Blood Cancer FDA approves AbbVie's all-oral leukemia treatment combo, showing better three-year outcomes and offering patients a chance for time off therapy compared to standard chemo.
benzinga.com AbbVie, SLB, Amphenol, And More On CNBC's 'Final Trades' On CNBC's "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors recommended staying long on AbbVie.
benzinga.com Alibaba, IBM, Nu Holdings And More: CNBC's 'Final Trades' Analysts predict good earnings for IBM on Jan. 28. Alibaba forms nuclear power partnership for AI, while iShares and Nu are expected to do well.
benzinga.com Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.
benzinga.com Why Is Co-Diagnostics Stock Sinking Tuesday? Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint venture, causing concerns about dilution.
benzinga.com Wellgistics And DataVault Team Up To Transform Prescription Tracking DataVault AI and Wellgistics Health are collaborating to bring blockchain technology to the US prescription drug market.
benzinga.com NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
benzinga.com US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.
benzinga.com Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.
benzinga.com World Health Organization Responds to Trump's Order, Reminds Decades of Successful Health Achievements Trump signs an order to withdraw the U.S. from WHO, citing pandemic mismanagement, political influence, and inequitable funding, reigniting a past debate.
benzinga.com Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
benzinga.com FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.
benzinga.com Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
benzinga.com Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments.
benzinga.com From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as…- benzinga.com Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19 The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or sev
benzinga.com 9 Million American Children Lost Funding For Their Insurance 
benzinga.com Government Study: Cellphone Radiation Linked To Cancer - benzinga.com Are We Seeing A Sector Rotation Away From Financials And Into Healthcare?
- benzinga.com Healthcare ETFs Unmoved By Possible Humana Inc. Merger
- benzinga.com Five Health Care ETFs Your Broker Forget To Mention
- benzinga.com Twelve Health Care ETFs Trading Near 52-Week Highs